AGA and Rx.Health Create Virtual Care Hub and Telehealth to Support GI Practices During the COVID-19 Crisis

In response to the COVID-19 crisis, the American Gastroenterological Association (AGA) and Rx.Health has announced the launch of a nationwide Virtual Care Hub and Telehealth facility for GI practices. The initiative expands upon their existing partnership providing the GI community with an endoscopy transformation network.

The Virtual Care Hub and Telehealth, delivered via Rx.Health’s digital health platform will support digital screening and triage of patients before in-person appointments, conducting virtual visits through a dedicated telehealth room for each provider, and digital prescription of GI education modules including those from the AGA patient education center.

“This is a period of crisis for not only our patients and communities but also for health care organizations and GI practices nationwide,” said Tom Serena, CEO of AGA. “By supporting seamless transition to virtual care, we are enabling a new model that allows AGA to support continuity of care during the COVID-19 crisis and help our members, patients, and communities.”

“Through AGA’s unparalleled subject matter, we have been able to support multiple health systems and ambulatory surgical centers with our full suite of perioperative, evidence-based digital solutions as a plug-and-play turnkey solution,” said Gaurav Narang, VP Strategic partnerships at Rx.Health. “Through industry partnerships, we are now able to extend the current model and support a comprehensive virtual care model including patient onboarding, appointment reminders, telehealth visits, and post-visit follow up – at a fraction of the normal cost.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”